Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed. eje anparter i et speciallægeselskab samt aktiviteter i tilknytning hertil.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2.4 mio. | -25 t. | 1.5 mio. | 222 t. | 1 | |
CVR: 40180087
Compared to 624 companies in Speciallægers aktiviteter
Comparison is based on industry median values
The financial health of Speciallægeselskabet Københavns Smerteklinik ApS shows signs of instability, with a notable decline in profitability over the past few years. Revenue decreased from 2,662,649 DKK in 2024 to 2,365,638 DKK in 2025, while the company reported a loss of 25,383 DKK in 2025, following a smaller loss of 12,505 DKK in 2024. Equity has also declined from 259,704 DKK in 2023 to 221,816 DKK in 2025, indicating potential concerns regarding financial sustainability. Despite experiencing a profit of 15,662 DKK in 2023, the overall trend suggests challenges in maintaining profitability and revenue growth, positioning the company in a precarious state within the specialized medical services industry.
AI-generated summary
Companies in the same industry and area
companydata.dk